Cover Image
市場調查報告書

高內涵篩選 (HCS) 的全球市場

High Content Screening (HCS)

出版商 Global Industry Analysts, Inc. 商品編碼 248868
出版日期 內容資訊 英文 202 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
高內涵篩選 (HCS) 的全球市場 High Content Screening (HCS)
出版日期: 2016年02月01日 內容資訊: 英文 202 Pages
簡介

本報告提供全球全球高內涵篩選 (HCS) 市場相關調查,彙整從2014年到2020年的市場成長預測,各地區趨勢,以及進入此市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • HCS:發展中的篩檢技術
    • 有成長機會的市場
    • 主要的市場成長促進要素
    • 主要課題
    • 市場預測
    • 發展中國家推動未來的成長
    • HCS軟體:高成長市場
    • 設備銷售額持續擴大
    • 醫藥品產業的不景氣對消耗品及設備預測給予打擊
    • 競爭概要
    • 市場主要參與企業
    • 創業投資的投資金持續增加
  • 市場趨勢與課題
    • 作為主要篩檢法之發展
    • 技術演進促進市場成長
    • 政府的輔助帶給市場正面影響
    • HCS的主要用戶──學術部門的出現
    • 幹細胞生物學:新興關心領域
    • HCS特有資料分析系統
    • HCS和HTS
    • HTS實驗室HCS技術引進的擴大
    • 市場課題
    • 設備成本高阻礙成長
  • 產品概要
  • 產品簡介/創新
  • 近幾年的產業活動
  • 主要企業
    • BD Biosciences
    • BioTek Instruments Inc.
    • Definiens AG
    • EMD Millipore
    • Evotec AG
    • Fluxion Biosciences, Inc.
    • GE Healthcare Life Sciences
    • Genedata AG
    • IntelliCyt Corporation
    • Molecular Devices Inc.
    • PerkinElmer Inc
    • Roche Applied Sciences
    • Thermo Fisher Scientific, Inc.
    • Thorlabs, Inc.
    • TTP LabTech Ltd.
    • 橫河電機
  • 全球市場預測

第3章 市場

  • 美國
  • 日本
  • 加拿大
  • 歐洲

第4章 競爭環境

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6754

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The Global market is further analyzed by the following Segments: Consumables, Instruments, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 73 companies including many key and niche players such as -

BD Biosciences
BioTek Instruments Inc.
Definiens AG
EMD Millipore
Evotec AG

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Consumables
    • Instrumentation
    • Others
      • Software
      • Services

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • HCS - An Evolving Screening Technology
  • HCS Market Ripe with Growth Opportunity
  • Key Growth Drivers
  • Key Challenges
  • Market Outlook
  • Developing Regions Drive Future Growth
    • Table 1: Global High Content Screening (HCS) Market - Geographic Regions Ranked by CAGR for 2014-2020 (includes corresponding Graph/Chart)
  • HCS Software - A High Growth Market
  • Equipment Sales Continue to Expand
  • Recession in Pharma Industry Hits Prospects for Consumables and Instruments
  • Competitive Overview
  • Focus on Key Players in the HCS Market
    • BD Biosciences
    • Thermo Fisher Scientific Inc.
    • GE Healthcare
    • PerkinElmer Inc.
    • Table 2: Leading Players in the Global HCS Market (2015E): Percentage Share Breakdown for BD Biosciences, GE Healthcare, PerkinElmer, Molecular Devices, Thermo Fisher Scientific, Thorlabs, and Others (includes corresponding Graph/Chart)
  • Venture Capital Investments Continue to Grow

2. MARKET TRENDS AND ISSUES

  • HCS - Evolves as Primary Screening Method
    • Table 3: Global Screening Market (2014): Percentage Share Breakdown by Segment - Primary Screening, Secondary Screening and Leads-to-Candidate (ADME/Tox Screening) (includes corresponding Graph/Chart)
  • Technology Advancements Spearhead Market Growth
  • Government Support Bodes Well for the Market
  • Emergence of Academic Sector as the Major User of HCS
    • Table 4: HCS Budget of a Typical Research Company (includes corresponding Graph/Chart)
    • Table 5: Global High-Throughput Screening Market (2015): Percentage Breakdown of Sales by End-use Segment (includes corresponding Graph/Chart)
  • Stem Cell Biology - An Emerging Area of Interest
  • HCS Specific Data Analysis Systems - The Need of the Hour
  • HCS vs. HTS
  • Rise in Adoption of HCS Technology in HTS Laboratories
  • Market Challenges
  • High Instrumentation Costs Hamper Rapid Growth

3. PRODUCT OVERVIEW

  • Defining High Content Screening
  • The Process of High Content Screening
  • The Process of High Content Screening
  • Technology Evolves Over the Years
  • HCS Tools
  • List of HCS Tools
  • HCS Imaging - Categories
  • Instrumentation
  • Consumables
  • Software
  • Services

4. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Molecular Devices Launches New ImageXpressR Micro Confocal HCS
  • CYTOO Launches MyoScreenφ? Platform
  • Molecular Devices Unveils EarlyTox? Cell Viability Assay Kits
  • Molecular Devices Introduces FLIPRR Potassium Assay Kit
  • IntelliCyt Unveils iQueR Screener PLUS
  • BioTek Launches Cytation? 5 Cell Imaging Multi-Mode Reader
  • Genedata Launches Genedata ScreenerR 12
  • Thermo Fisher Scientific Introduces New CeLLInsight CX5 HCS Platform
  • PerkinElmer Introduces Opera Phenix? Next-Gen HCS System
  • Molecular Devices Unveils ImageXpressR Micro XLS System
  • TMO Unveils HCS Studio Software
  • Molecular Devices Launches FLIPRR Calcium 6 Assay Kits
  • TMO Expands its HCS Portfolio with Three New Products
  • Cytoo Introduces 2D+ Solutions
  • TTP Labtech Unveils Acumen High Content Imaging System

5. RECENT INDUSTRY ACTIVITY

  • Genedata Forms Alliance with IntelliCyt
  • Harlan Inks Strategic Partnership with Fluofarma
  • BioTech Inks Distribution Agreement with IDEA Bio-Medical

6. FOCUS ON SELECT GLOBAL PLAYERS

  • BD Biosciences (US)
  • BioTek Instruments Inc. (US)
  • Definiens AG (Germany)
  • EMD Millipore (US)
  • Evotec AG (Germany)
  • Essen BioScience (US)
  • Fluxion Biosciences, Inc. (US)
  • GE Healthcare Life Sciences (Sweden)
  • Genedata AG (Switzerland)
  • IntelliCyt Corporation (US)
  • Molecular Devices Inc. (US)
  • PerkinElmer Inc. (US)
  • Roche Applied Sciences (Germany)
  • Thermo Fisher Scientific, Inc. (US)
  • Thorlabs, Inc. (US)
  • TTP LabTech Ltd. (UK)
  • Yokogawa Electric Corporation (Japan)

7. GLOBAL MARKET PERSPECTIVE

    • Table 6: World Recent Past, Current & Future Analysis for High Content Screening by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 7: World Historic Review for High Content Screening by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 8: World 14-Year Perspective for High Content Screening by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 9: World Recent Past, Current & Future Analysis for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 11: World 14-Year Perspective for High Content Screening by Segment - Percentage Breakdown of Revenues for Consumables, Instruments, and Others Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Overview
    • Product Launches
    • Recent Industry Activity
    • Key Players
  • B. Market Analytics
    • Table 12: US Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 13: US Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 14: Canadian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 15: Canadian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Yokogawa Electric Corporation - A Key Player
  • B. Market Analytics
    • Table 16: Japanese Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 17: Japanese Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Clinical Trials Market in Europe
  • B. Market Analytics
    • Table 18: European Recent Past, Current & Future Analysis for High Content Screening by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: European Historic Review for High Content Screening by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 20: European 14-Year Perspective for High Content Screening by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Outlook
    • Corporate Development
    • Fluofarma SA - A Key Player
  • B. Market Analytics
    • Table 21: French Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 22: French Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Key Players
  • B. Market Analytics
    • Table 23: German Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 24: German Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 25: Italian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 26: Italian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Product Launch
    • Key Players
  • B. Market Analytics
    • Table 27: The UK Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 28: The UK Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Outlook
  • B. Market Analytics
    • Table 29: Spanish Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: Spanish Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Product Launch
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 31: Rest of Europe Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 32: Rest of Europe Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Select Regional Analysis
      • China
      • China Emerges as the Major Outsourcer for Drug Discovery
      • India
  • B. Market Analytics
    • Table 33: Asia-Pacific Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 34: Asia-Pacific Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • Market Analysis
    • Table 35: Rest of World Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 36: Rest of World Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top